Report

Medicines in Development for Diabetes 2016 Report

Report

Medicines in Development for Diabetes 2016 Report

America’s biopharmaceutical research companies are currently developing more than 170 innovative new medicines to help the more than 30 million Americans affected by diabetes

Policy Paper

Promoting a Proactive Policy Agenda

Policy Paper

Policy Solutions

From PhRMA

People Behind the Science

From PhRMA

People Behind the Science

Video

I’m Not Average – Matt

Video

I'm Not Average: Matt Survives Cancer Despite the Odds

Report

Prescription Medicines: Costs in Context

Report

Prescription Medicines: Costs in Context

The Pharmaceutical Research and Manufacturers of America, PhRMA, represents the country’s leading biopharmaceutical researchers and biotechnology companies.

Latest From TheBlog

World AIDS Day 2016: A decade of scientific innovation

By Andrew Powaleny on December 1, 2016 at 09:00 AM

10 years of living and managing type 1 diabetes; lessons learned

By Guest Contributor on November 30, 2016 at 12:00 PM

ICER glosses over significant progress in MS treatment

By Holly Campbell on November 30, 2016 at 09:00 AM

Medicare Monday: Open enrollment ends December 7! Last call to shop around

By Ashley Flint on November 28, 2016 at 09:00 AM